10-Q Filing

BIO GREEN MED SOLUTION, INC. CIK: 1130166 Q2 2011

Filing Information

Form Type	10-Q
Accession Number	`0000950123-11-076776`
Period End Date	20110630
Filing Date	20110812
Fiscal Year	2011
Fiscal Period	Q2
XBRL Instance	cycc-20110630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 56 Income Statement 106 Cash Flow Statement 96

Balance Sheet 56 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.61M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.54M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$11.49M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Inventory	`InventoryFinishedGoodsNetOfReserves`	$147.00K	USD	Point-in-time
Inventory	`InventoryFinishedGoodsNetOfReserves`	$174.00K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssets`	$1.69M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	1.21M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssets`	$1.38M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$31.05M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$22.45M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	1.21M	shares	Point-in-time
Preferred stock, liquidation preference value	`PreferredStockLiquidationPreferenceValue`	$13.34B	USD	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$246.00K	USD	Point-in-time
Property, plant and equipment (net)	`PropertyPlantAndEquipmentNet`	$408.00K	USD	Point-in-time
Preferred stock, liquidation preference value	`PreferredStockLiquidationPreferenceValue`	$13.34B	USD	Point-in-time
Total assets	`Assets`	$22.70M	USD	Point-in-time
Total assets	`Assets`	$31.46M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	46.56M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	46.59M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	46.59M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	46.56M	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.10M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.72M	USD	Point-in-time
Accrued liabilities and other current liabilities	`AccruedLiabilitiesCurrent`	$4.13M	USD	Point-in-time
Accrued liabilities and other current liabilities	`AccruedLiabilitiesCurrent`	$4.46M	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$680.00K	USD	Point-in-time
Warrant liability	`WarrantsAndRightsOutstanding`	$477.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.04M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$6.54M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.54M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.04M	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2010 and June 30, 2011; 1,213,142 shares issued and outstanding at December 31, 2010 and June 30, 2011. Aggregate preference in liquidation (including undeclared cumulative dividends) of $13,344,562 at December 31, 2010 and June 30, 2011	`PreferredStockValue`	$1.00K	USD	Point-in-time
Preferred stock, $0.001 par value; 5,000,000 shares authorized at December 31, 2010 and June 30, 2011; 1,213,142 shares issued and outstanding at December 31, 2010 and June 30, 2011. Aggregate preference in liquidation (including undeclared cumulative dividends) of $13,344,562 at December 31, 2010 and June 30, 2011	`PreferredStockValue`	$1.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2010 and June 30, 2011; 46,564,914 and 46,587,182 shares issued and outstanding at December 31, 2010 and June 30, 2011 respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Common stock, $0.001 par value; 100,000,000 shares authorized at December 31, 2010 and June 30, 2011; 46,564,914 and 46,587,182 shares issued and outstanding at December 31, 2010 and June 30, 2011 respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$266.53M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$266.67M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$31.00K	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$39.00K	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-241.82M	USD	Point-in-time
Deficit accumulated during the development stage	`RetainedEarningsAccumulatedDeficit`	$-249.96M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.66M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$24.92M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$31.46M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$22.70M	USD	Point-in-time

Income Statement 106 line items

Line Item	Tag	Value	Unit	Period
Collaboration and research and development revenue	`LicenseAndServicesRevenue`	$3.10M	USD	60 Qtrs
Collaboration and research and development revenue	`LicenseAndServicesRevenue`	$100.00K	USD	2 Qtrs
Collaboration and research and development revenue	`LicenseAndServicesRevenue`	$100.00K	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$168.00K	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$273.00K	USD	2 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$360.00K	USD	2 Qtrs
Product revenue	`SalesRevenueGoodsNet`	$19.00K	USD	1 Quarter
Product revenue	`SalesRevenueGoodsNet`	$2.68M	USD	60 Qtrs
Grant revenue	`RevenueFromGrants`	$16.00K	USD	2 Qtrs
Grant revenue	`RevenueFromGrants`	$3.65M	USD	60 Qtrs
Total revenue	`SalesRevenueNet`	$9.43M	USD	60 Qtrs
Total revenue	`SalesRevenueNet`	$168.00K	USD	1 Quarter
Total revenue	`SalesRevenueNet`	$389.00K	USD	2 Qtrs
Total revenue	`SalesRevenueNet`	$360.00K	USD	2 Qtrs
Total revenue	`SalesRevenueNet`	$119.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$1.57M	USD	60 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$72.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$178.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$234.00K	USD	2 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$92.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.86M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$4.94M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$181.53M	USD	60 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.50M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.32M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.09M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.84M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$85.81M	USD	60 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$5.49M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$2.03M	USD	1 Quarter
Goodwill and intangibles impairment	`GoodwillImpairmentLoss`	$7.93M	USD	60 Qtrs
Restructuring costs	`RestructuringCharges`	$2.63M	USD	60 Qtrs
Total operating expenses	`CostsAndExpenses`	$9.22M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$279.48M	USD	60 Qtrs
Total operating expenses	`CostsAndExpenses`	$3.96M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$8.96M	USD	2 Qtrs
Total operating expenses	`CostsAndExpenses`	$4.50M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.39M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-270.05M	USD	60 Qtrs
Operating loss	`OperatingIncomeLoss`	$-8.60M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-8.83M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.80M	USD	1 Quarter
Costs associated with aborted 2004 IPO	`PaymentsOfFinancingCosts`	$-3.55M	USD	60 Qtrs
Payment under guarantee	`PaymentUnderGuarantee`	$1.65M	USD	60 Qtrs
Change in valuation of derivative	`GainLossOnDerivativeInstrumentsNetPretax`	$-308.00K	USD	60 Qtrs
Change in valuation of warrants	`ChangeInValuationOfWarrants`	$-6.27M	USD	60 Qtrs
Change in valuation of warrants	`ChangeInValuationOfWarrants`	$-273.00K	USD	1 Quarter
Change in valuation of warrants	`ChangeInValuationOfWarrants`	$-203.00K	USD	2 Qtrs
Change in valuation of warrants	`ChangeInValuationOfWarrants`	$516.00K	USD	2 Qtrs
Change in valuation of warrants	`ChangeInValuationOfWarrants`	$-125.00K	USD	1 Quarter
Warrant re-pricing	`GainLossOnPriceRisksDerivativesNet`	$-44.00K	USD	60 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-87.00K	USD	2 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-38.00K	USD	2 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-4.34M	USD	60 Qtrs
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-19.00K	USD	1 Quarter
Foreign exchange (losses)/gains	`ForeignCurrencyTransactionGainLossBeforeTax`	$-49.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$13.70M	USD	60 Qtrs
Interest income	`InvestmentIncomeInterest`	$8.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$17.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$24.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$13.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$4.68M	USD	60 Qtrs
Interest expense	`InterestExpense`	$9.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$33.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$140.00K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$5.40M	USD	60 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$223.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$119.00K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-570.00K	USD	2 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-264.64M	USD	60 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.46M	USD	2 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-3.68M	USD	1 Quarter
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-9.40M	USD	2 Qtrs
Loss before taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.16M	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-230.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-126.00K	USD	1 Quarter
Income tax benefit	`IncomeTaxExpenseBenefit`	$-18.20M	USD	60 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-363.00K	USD	2 Qtrs
Income tax benefit	`IncomeTaxExpenseBenefit`	$-317.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-246.45M	USD	60 Qtrs
Net loss	`NetIncomeLoss`	$-3.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.93M	USD	1 Quarter
Dividends on preferred ordinary shares	`DividendsOnPreferredOrdinaryShares`	$38.12M	USD	60 Qtrs
Deemed dividend on convertible exchangeable preferred shares	`RedeemablePreferredStocksDividends`	$2.50M	USD	1 Quarter
Deemed dividend on convertible exchangeable preferred shares	`RedeemablePreferredStocksDividends`	$2.92M	USD	2 Qtrs
Deemed dividend on convertible exchangeable preferred shares	`RedeemablePreferredStocksDividends`	$3.52M	USD	60 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$3.29M	USD	60 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$364.00K	USD	2 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$182.00K	USD	1 Quarter
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$403.00K	USD	2 Qtrs
Dividend on convertible exchangeable preferred shares	`DividendsPreferredStocks`	$114.00K	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.73M	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.54M	USD	1 Quarter
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.36M	USD	2 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-8.50M	USD	2 Qtrs
Net loss applicable to common shareholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-291.38M	USD	60 Qtrs
Net loss per share- Basic and diluted	`EarningsPerShareBasic`	$-0.08	USD	1 Quarter
Net loss per share- Basic and diluted	`EarningsPerShareBasic`	$-0.18	USD	2 Qtrs
Net loss per share- Basic and diluted	`EarningsPerShareBasic`	$-0.36	USD	2 Qtrs
Net loss per share- Basic and diluted	`EarningsPerShareBasic`	$-0.18	USD	1 Quarter
Weighted average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	34.16M	shares	2 Qtrs
Weighted average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	46.58M	shares	2 Qtrs
Weighted average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	36.57M	shares	1 Quarter
Weighted average common shares outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	46.58M	shares	1 Quarter

Cash Flow Statement 96 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-246.45M	USD	60 Qtrs
Net loss	`NetIncomeLoss`	$-3.55M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-8.14M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-9.04M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.93M	USD	1 Quarter
Accretion of interest on notes payable, net of amortization of debt premium	`AccretionExpense`	$100.00K	USD	60 Qtrs
Accretion of interest on notes payable, net of amortization of debt premium	`AccretionExpense`	$2.00K	USD	2 Qtrs
Amortization of investment premiums, net	`InvestmentIncomeAmortizationOfPremium`	$-2.30M	USD	60 Qtrs
Change in valuation of derivative	`UnrealizedGainLossOnDerivatives`	$-308.00K	USD	60 Qtrs
Change in valuation of warrants	`ChangeInValuationOfWarrantsAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities`	$-203.00K	USD	2 Qtrs
Change in valuation of warrants	`ChangeInValuationOfWarrantsAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities`	$516.00K	USD	2 Qtrs
Change in valuation of warrants	`ChangeInValuationOfWarrantsAdjustmentsToReconcileNetLossToNetCashUsedInOperatingActivities`	$-6.27M	USD	60 Qtrs
Warrant re-pricing	`GainLossOnPriceRisksDerivativesNet`	$-44.00K	USD	60 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$240.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$172.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$12.49M	USD	60 Qtrs
Amortization of intangible assets	`AmortizationOfIntangibleAssets`	$886.00K	USD	60 Qtrs
Fixed asset impairment	`ImpairmentOfLongLivedAssetsHeldForUse`	$221.00K	USD	60 Qtrs
Goodwill and intangibles impairment	`GoodwillImpairmentLosses`	$7.93M	USD	60 Qtrs
Unrealized foreign exchange loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-21.00K	USD	2 Qtrs
Unrealized foreign exchange loss	`ForeignCurrencyTransactionGainLossUnrealized`	$-7.77M	USD	60 Qtrs
Deferred revenue	`RecognitionOfDeferredRevenue`	$98.00K	USD	60 Qtrs
Compensation for warrants issued to non employees	`StockOptionPlanExpenses`	$1.22M	USD	60 Qtrs
Shares issued for IP rights	`IssuanceOfStocksAndWarrantsForServicesOrClaims`	$446.00K	USD	60 Qtrs
(Gain) loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-99.00K	USD	60 Qtrs
(Gain) loss on disposal of property, plant and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$9.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$455.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$786.00K	USD	2 Qtrs
Stock based compensation	`ShareBasedCompensation`	$18.60M	USD	60 Qtrs
Provision for restructuring	`PaymentsForRestructuring`	$-1.78M	USD	60 Qtrs
Amortization of issuance costs of Preferred Ordinary "C" shares	`AmortizationOfFinancingCostsAndDiscounts`	$2.52M	USD	60 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$279.00K	USD	2 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$511.00K	USD	60 Qtrs
Prepaid expenses, inventory and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$88.00K	USD	2 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayable`	$-2.18M	USD	2 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayable`	$-482.00K	USD	2 Qtrs
Accounts payable, accrued liabilities and other current liabilities	`IncreaseDecreaseInAccountsPayable`	$-6.37M	USD	60 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-9.78M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-207.60M	USD	60 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.46M	USD	2 Qtrs
Purchase of ALIGN	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$3.76M	USD	60 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.00K	USD	2 Qtrs
Purchase of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$8.83M	USD	60 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$158.00K	USD	60 Qtrs
Proceeds from sale of property, plant and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$35.00K	USD	2 Qtrs
Purchase of short-term investments	`PaymentsToAcquireShortTermInvestments`	$156.66M	USD	60 Qtrs
Redemptions of short-term investments, net of maturities	`ProceedsFromSaleOfShortTermInvestments`	$162.73M	USD	60 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-6.36M	USD	60 Qtrs
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$27.00K	USD	2 Qtrs
Payment of capital lease obligations	`RepaymentsOfLongTermCapitalLeaseObligations`	$3.72M	USD	60 Qtrs
Proceeds from issuance of ordinary and preferred ordinary shares, net of issuance costs	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$121.68M	USD	60 Qtrs
Proceeds from issuance of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$15.15M	USD	2 Qtrs
Proceeds from issuance of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$-80.00K	USD	2 Qtrs
Proceeds from issuance of common stock and warrants, net of issuance costs	`ProceedsFromIssuanceOfCommonStock`	$82.32M	USD	60 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$3.00K	USD	2 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$2.70M	USD	2 Qtrs
Net proceeds from stock options and warrants exercised	`ProceedsFromStockOptionsExercised`	$173.00K	USD	60 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$1.90M	USD	60 Qtrs
Payment of preferred stock dividend	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$364.00K	USD	2 Qtrs
Repayment of government loan	`PaymentForLoans`	$455.00K	USD	60 Qtrs
Government loan received	`ProceedsFromNotesPayable`	$414.00K	USD	60 Qtrs
Loan received from Cyclacel Group Plc	`ProceedsFromLoans`	$9.10M	USD	60 Qtrs
Proceeds of committable loan notes issued from shareholders	`ProceedsOfCommittableLoanNotesIssuedFromShareholders`	$8.88M	USD	60 Qtrs
Loans received from shareholders	`LoansAndLeasesReceivableRelatedPartiesCollections`	$-1.65M	USD	60 Qtrs
Cash and cash equivalents assumed on stock purchase	`CashAcquiredFromAcquisition`	$17.91M	USD	60 Qtrs
Costs associated with stock purchase	`PaymentsForRepurchaseOfEquity`	$1.95M	USD	60 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-441.00K	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$234.11M	USD	60 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$17.86M	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-56.00K	USD	2 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$464.00K	USD	60 Qtrs
Effect of exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$16.00K	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$8.05M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$20.61M	USD	60 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-8.88M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$20.61M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$19.54M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$11.49M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$20.61M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$19.54M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$11.49M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$29.50M	USD	Point-in-time
Interest	`ProceedsFromInterestReceived`	$11.00K	USD	2 Qtrs
Interest	`ProceedsFromInterestReceived`	$11.00K	USD	2 Qtrs
Interest	`ProceedsFromInterestReceived`	$11.73M	USD	60 Qtrs
Taxes	`ProceedsFromIncomeTaxRefunds`	$110.00K	USD	2 Qtrs
Taxes	`ProceedsFromIncomeTaxRefunds`	$17.52M	USD	60 Qtrs
Interest	`InterestPaidNet`	$-1.91M	USD	60 Qtrs
Interest	`InterestPaidNet`	$-187.00K	USD	2 Qtrs
Acquisitions of equipment purchased through capital leases	`AcquisitionsOfEquipmentPurchasedThroughCapitalLeases`	$3.47M	USD	60 Qtrs
Issuance of common shares in connection with license agreements	`IssuanceOfOrdinarySharesInConnectionWithLicenseAgreements`	$592.00K	USD	60 Qtrs
Issuance of Ordinary shares on conversion of bridging loan	`IssuanceOfOrdinarySharesOnConversionOfBridgingLoan`	$1.64M	USD	60 Qtrs
Issuance of Preferred Ordinary "C" shares on conversion of secured convertible loan notes and accrued interest	`IssuanceOfPreferredOrdinaryClassCSharesOnConversionOfSecuredConvertibleLoanNotesAndAccruedInterest`	$8.89M	USD	60 Qtrs
Issuance of Ordinary shares in lieu of cash bonus	`IssuanceOfOrdinarySharesInLieuOfCashBonus`	$164.00K	USD	60 Qtrs
Issuance of other long term payable on ALIGN acquisition	`IssuanceOfOtherLongTermPayableOnAlignAcquisition`	$1.12M	USD	60 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.